BioCentury
ARTICLE | Clinical News

Medarex data

August 9, 1993 7:00 AM UTC

The MDX-210 Bispecific antibody used in conjunction with granulocyte-colony stimulating factor (G-CSF) can target neutrophils at ovarian cancer, according to in vitro data published in the August issu...